debt rating Fitch Rates Abbott Notes Offering at A(EXP) The ratings agency also assigned a Negative Rating Watch to the firm's notes offering, noting it will resolve this notation as more details of the offering become available. Fitch Assigns BBB Rating to Thermo Fisher Scientific €1.6B Senior Notes Offering The rating agency said it expects that the company will use the proceeds from the offering to finance its $4.2 billion acquisition of FEI. Thermo Fisher Scientific Plans Offering of €600M in Senior Notes Fitch has given the two-year senior notes offering a BBB rating with a Stable outlook. PerkinElmer Prices €500M Senior Note Offering The 10-year notes were rated BBB by Fitch, which also declared the ratings outlook Stable. Thermo Fisher Prices $1B of Senior Notes The firm plans to use the proceeds, along with cash on hand, to redeem its outstanding $1 billion senior notes that mature August 15. Apr 4, 2016 Thermo Fisher Senior Notes Offering Rated BBB by Fitch Nov 25, 2015 Fitch Affirms Bio-Rad Debt Rating Sep 17, 2015 Fitch Upgrades PerkinElmer Debt Rating Apr 22, 2015 Fitch Affirms BBB Rating for Quest Mar 5, 2015 Fitch Assigns BBB Rating to Quest's Senior Notes Offering Dec 18, 2014 Fitch Affirms Thermo Fisher Ratings, Raises Outlook to Stable Nov 6, 2014 Thermo Fisher Plans $800M Senior Notes Offering; Fitch Issues BBB Rating for Firm's Notes Dec 4, 2013 Fitch Downgrades Thermo Fisher's Issuer Default Rating Sep 19, 2013 Fitch Affirms Agilent Debt Ratings; Revises Outlook to Stable Apr 16, 2013 Fitch Places Thermo Fisher, Life Tech Ratings on Negative Watch after Announcement of $13.6B Deal Jan 29, 2013 Fitch Places Life Tech's Ratings on Evolving Watch Following Acquisition Speculation Nov 14, 2012 Bio-Rad Ratings Affirmed by Fitch Sep 21, 2012 Fitch Affirms PerkinElmer Ratings, Saying Outlook is Stable Sep 10, 2012 Agilent Prices Public Offering of Senior Notes at $400M Aug 15, 2012 Thermo Fisher to Offer Senior Notes to Fund Acquisition Apr 17, 2012 Fitch Affirms BBB+ Ratings for Agilent Mar 7, 2012 Moody's Upgrades Life Technologies' Senior Notes Feb 6, 2012 Fitch Affirms Life Technologies Rating May 19, 2011 Fitch Affirms Rating for Thermo Fisher Scientific Apr 21, 2011 Fitch Upgrades Agilent to BBB+ Rating Breaking News FDA Revises SARS-CoV-2 Test Emergency Use Authorization Requirements to Account for Variants Geisinger Wins $5M NIH Grant to Develop Point-of-Care Genetic Diagnostic Tool Second Genome, Virginia Commonwealth University Partner on NASH Biomarker Discovery LGC Receives CE Mark for AccuPlex SARS-CoV-2, Flu A/B, RSV Reference Material Kit Esophageal Cancer Testing Firm Lucid Diagnostics Files For IPO Twist Bioscience, DeepCDR Collaborate on Antibody Library Design The Scan Booster for At-Risk The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk. Preprints OK to Mention Again Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications. Hundreds of Millions More to Share The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post. Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.